Lymphatic Filariasis: Treatment, Control and Elimination

Advances in Parasitology

Volumn 61, Issue , 2006, Pages 395-441

  Ottesen, Eric A ^a  

^a Lymphatic Filariasis Support Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; DOXYCYCLINE; IVERMECTIN;

ELEPHANTIASIS; FILARIASIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HUMAN; HYDROCELE; LYMPHATIC SYSTEM INFECTION; LYMPHEDEMA; MICROFILARIASIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; WUCHERERIA BANCROFTI;

ANIMALS; ANTHELMINTICS; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; HUMANS; INSECT VECTORS; MOSQUITO CONTROL; NATIONAL HEALTH PROGRAMS; PUBLIC HEALTH; WORLD HEALTH;

EID: 33646823291     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(05)61010-X     Document Type: Review

References (90)

1. Addiss, D.G. and Brady, M.A. (2005). Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis-a review of the scientific literature. Background paper. Special Programme for Research and Training in Tropial Diseases (TDR) Scientific Working Group Meeting on Lymphatic Filariasis, May 2005, Geneva.
2. Amaral F., Dreyer G., Figueredo-Silva J., Noroes J., Cavalcanti A., Samico S.C., Santos A., and Coutinho A. Live adult worms detected by ultrasonography in human Bancroftian filariasis. American Journal of Tropical Medicine and Hygiene 50 (1994) 753-757
3. Beau De Rochars M.B., Direny A.N., Roberts J.M., Addiss D.G., Radday J., Beach M.J., Streit T.G., Dardith D., Lafontant J.G., and Lammie P.J. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. American Journal of Tropical Medicine and Hygiene 71 (2004) 466-470
4. Beaver P.C. Filariasis without microfilaremia. American Journal of Tropical Medicine and Hygiene 19 (1970) 181-189
5. Belizario V.Y., Amarillo M.E., de Leon W.U., de los Reyes A.E., Bugayong M.G., and Macatangay B.J. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bulletin of the World Health Organization 81 (2003) 35-42
6. Bockarie M.J., Tavul L., Kastens W., Michael E., and Kazura J.W. Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea. Medical and Veterinary Entomology 16 (2002) 116-119
7. Bradley, M.L. and Kumaraswami, V. (2004). Towards a strategic plan for research to support the Global Program to Eliminate Lymphatic Filariasis. 2. Reserach directly linked with GPELF activities (operational research). 2.2. Essential tools-drugs and clinical drug trials. American Journal of Tropical Medicine and Hygiene 71, supplement, 7-11.
8. Burkot, T. and Bockarie, M.J. (2004). Towards a strategic plan for research to support the Global Program to eliminate lymphatic filariasis. 2. Research directly linked with GPELF activities (operational research). 2.7. Vectors. American Journal of Tropical Medicine and Hygiene 71, supplement, 24-26.
9. Burkot T., and Ichimori K. The PacELF programme: will mass drug administration be enough?. Trends in Parasitology 18 (2002) 109-115
10. Centers for Disease Control and Prevention (1993). Recommendations of the International Task Force for Disease Eradication. Morbidity and Mortality Weekly Report 42, 1-38.
11. Chernin E. The disappearance of Bancroftian filariasis from Charleston, South Carolina. American Journal of Tropical Medicine and Hygiene 37 (1987) 111-114
12. Colatrella B. The Mectizan Donation Programme-successful collaboration between the public and private sectors. Essential Drugs Monitor 33 (2003) 28-29
13. Cooper P.J., Chico M.E., Losonsky G., Sandoval C., Espinel I., Sridhara R., Aguilar M., Guevara A., Guderian R.H., Levine M.M., Griffin G.E., and Nutman T.B. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. Journal of Infectious Diseases 182 (2000) 1199-1206
14. Crompton D.W. The public health importance of hookworm disease. Parasitology 121 supplement (2000) S39-S50
15. Curtis C.F., Malecela-Lazaro M., Reuben R., and Maxwell C.A. Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus. Annals of Tropical Medicine and Parasitology 96 supplement 2 (2002) S97-S104
16. DeVries C.R. The role of the urologist in the treatment and elimination of lymphatic filariasis worldwide. British Journal of Urology 89 supplement 1 (2002) 37-43
17. Dreyer, G., Addiss, D., Dreyer, P. and Noroes, J. (2002). Basic Lymphoedema Management: Treatment and Prevention of Problems Associated with Lymphatic Filariasis, pp. 112. Hollis, New Hampshire: Hollis Publishing Company.
18. Dreyer G., Addiss D., Noroes J., Amaral F., Rocha A., and Coutinho A. Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian filariasis. Tropical Medicine and International Health 1 (1996) 427-432
19. Dreyer G., Amaral F., Noroes J., Medeiros Z., and Addiss D. A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for Bancroftian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 89 (1995) 225-226
20. Dreyer G., Figueredo-Silva J., Carvalho K., Amaral F., and Ottesen E.A. Lymphatic filariasis in children: adenopathy and its evolution in two young girls. American Journal of Tropical Medicine and Hygiene 65 (2001) 204-207
21. Dreyer G., Noroes J., Figueredo-Silva J., and Piessens W.F. Pathogenesis of lymphatic disease in Bancroftian filariasis: a clinical perspective. Parasitology Today 16 (2000) 544-548
22. Dreyer G., Ottesen E.A., Galdino E., Andrade L., Rocha A., Medeiros Z., Moura I., Casimiro I., Beliz F., and Coutinho A. Renal abnormalities in microfilaremic patients with Bancroftian filariasis. American Journal of Tropical Medicine and Hygiene 46 (1992) 745-751
23. Druilhe P., Tall A., and Sokhna C. Worms can worsen malaria: towards a new means to roll back malaria?. Trends in Parasitology 21 (2005) 359-362
24. Eigege A., Richards Jr. F.O., Blaney D.D., Miri E.S., Gontor I., Ogah G., Umaru J., Jinadu M.Y., Mathai W., Amadiegwu S., and Hopkins D.R. Rapid assessment for lymphatic filariasis in central Nigeria: a comparison of the immunochromatographic card test and hydrocele rates in an area of high endemicity. American Journal of Tropical Medicine and Hygiene 68 (2003) 643-646
25. El Setouhy M., Ramzy R., Ahmed E., Kandil A., Hussain O., Farid H., Helmy H., and Weil G. A randomized clinical trial comparing single-multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of Bancroftian filariasis. American Journal of Tropical Medicine and Hygiene 70 (2004) 191-196
26. Fenwick A., Molyneux D., and Nantulya V. Achieving the millennium development goals. Lancet 365 (2005) 1029-1030
27. Fraser M., Taleo G., James Y., Amos M., Babu M., and Kalkoa M. Evaluation of the Program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodological approach. American Journal of Tropical Medicine and Hygiene 73 (2005) 753-758
28. Freedman D.O., de Almeida Filho P.J., Besh S., Maia e Silva M.C., Braga C., and Maciel A. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. Journal of Infectious Diseases 170 (1994) 927-933
29. Gubler D.J., and Bhattacharya N.C. A quantitative approach to the study of Bancroftian filariasis. American Journal of Tropical Medicine and Hygiene 23 (1974) 1027-1036
30. Gyapong J.O., Kumaraswami V., Biswas G., and Ottesen E.A. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opinion on Pharmacotherapy 6 (2005) 179-200
31. Gyapong J.O., Kyelem D., Kleinschmidt I., Agbo K., Ahouandogbo F., Gaba J., Owusu-Banahene G., Sanou S., Sodahlon Y.K., Biswas G., Kale O.O., Molyneux D.H., Roungou J.B., Thomson M.C., and Remme J. The use of spatial analysis in mapping the distribution of Bancroftian filariasis in four West African countries. Annals of Tropical Medicine and Parasitology 96 (2002) 695-705
32. Horton J., Witt C., Ottesen E.A., Lazdins J.K., Addiss D.G., Awadzi K., Beach M.J., Belizario V.Y., Dunyo S.K., Espinel M., Gyapong J.O., Hossain M., Ismail M.M., Jayakody R.L., Lammie P.J., Makunde W., Richard-Lenoble D., Selve B., Shenoy R.K., Simonsen P.E., Wamae C.N., and Weerasooriya M.V. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 121 supplement (2000) S147-S160
33. Houston R. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes. Parasitology 121 supplement (2000) S161-S173
34. Jayakody R.L., De Silva C.S., and Weerasinghe W.M. Treatment of Bancroftian filariasis with albendazole: evaluation of efficacy and adverse reactions. Tropical Biomedicine 10 (1993) 19-24
35. Katabarwa N.M., and Mutabazi D. Controlling onchocerciasis by community-directed, ivermectin-treatment programmes in Uganda: why do some communities succeed and others fail?. Annals of Tropical Medicine and Parasitology 94 (2000) 343-352
36. Krishna K., Harichandrakumar K., Das L., and Krishnamoorthy K. Physical and psychosocial burden due to lymphatic filariasis as perceived by patients and medical experts. Tropical Medicine and International Health 10 June (2005) 567-573
37. Laigret J., Kessel J.F., Bambridge B., and Adams H. 11 years of chemoprophylaxis of non-periodic lymphatic filariasis with diethylcarbamazine in Tahiti. Bulletin of the World Health Organization 34 (1966) 925-938
38. Lammie P.J., Weil G., Noordin R., Kaliraj P., Steel C., Goodman D., Lakshmikanthan V.B., and Ottesen E. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis-a multicenter trial. Filaria Journal 3 (2004) 9
39. Lizotte M.R., Supali T., Partono F., and Williams S.A. A polymerase chain reaction assay for the detection of Brugia malayi in blood. American Journal of Tropical Medicine and Hygiene 51 (1994) 314-321
40. Mani T.R., Rajendran R., Sunish I.P., Munirathinam A., Arunachalam N., Satyanarayana K., and Dash A.P. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme. Tropical Medicine and International Health 9 (2004) 1030-1035
41. McPherson, T., Persaud, S., Singh, S., Fay, M. P., Addiss, D., Nutman, T.B. and Hay, R. (2006). Interdigital lesions and acute dermatolymphangioadenitis in lymphatic filariasis. British Journal of Dermatology, in press.
42. Michael E., Malecela-Lazaro M.N., Simonsen P.E., Pedersen E.M., Barker G., Kumar A., and Kazura J.W. Mathematical modelling and the control of lymphatic filariasis. Lancet Infectious Diseases 4 (2004) 223-234
43. Molyneux D.H. "Neglected" diseases but unrecognised successes-challenges and opportunities for infectious disease control. Lancet 364 (2004) 380-383
44. Molyneux D.H., and Nantulya V.M. Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals. British Medical Journal 328 (2004) 1129-1132
45. Molyneux D.H., and Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Annals of Tropical Medicine and Parasitology 96 supplement 2 (2002) S15-S40
46. Nacher M., Singhasivanon P., Yimsamran S., Manibunyong W., Thanyavanich N., Wuthisen R., and Looareesuwan S. Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. Journal of Parasitology 88 (2002) 55-58
47. Noroes J., Dreyer G., Santos A., Mendes V.G., Medeiros Z., and Addiss D. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Transactions of the Royal Society of Tropical Medicine and Hygiene 91 (1997) 78-81
48. O'Lorcain P., and Holland C.V. The public health importance of Ascaris lumbricoides. Parasitology 121 supplement (2000) S51-S71
49. Olszewski W., Jamal S., Manokaran G., Pani S., Kumaraswami V., Kubicka U., Lukomska B., Dworczynski A., Dworczynski A., Swoboda E., and Meisel-Mikolajczyk F. Bacteriologic studies of skin, tissue fluid, lymph, and lymph nodes in patient with filarial lymphedema. American Journal of Tropical Medicine and Hygiene 57 (1997) 7-15
50. Onapa A.W., Simonsen P.E., Baehr I., and Pedersen E.M. Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens. Annals of Tropical Medicine and Parasitology 99 (2005) 141-153
51. Ottesen E.A. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Reviews of Infectious Diseases 7 (1985) 341-356
52. Ottesen E.A. Description, mechanisms and control of reactions to treatment in the human filariases. Ciba Foundation Symposium 127 (1987) 265-283
53. Ottesen E.A. The human filariases: new understandings, new therapeutic strategies. Current Opinion in Infectious Diseases (1994) 550-558
54. Ottesen E.A. The global programme to eliminate lymphatic filariasis. Tropical Medicine and International Health 5 (2000) 591-594
55. Ottesen E.A. Filariasis. In: Cohen J., and Powderly W. (Eds). Infectious Diseases (2004), Elsevier, London 1607-1613
56. Ottesen, E.A., Dowdle, W., Fenner, F., Habermehl, K., John, T., Koch, M., Medley, G., Muller, A., Ostroff, S. and Zeichhardt, H. (1998). How is eradication to be defined and what are the biological criteria? In: The Eradication of Infectious Diseases (W. Dowdle and D. Hopkins, eds). Wiley. Chickester, UK.
57. Ottesen E.A., Duke B.O., Karam M., and Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization 75 (1997) 491-503
58. Ottesen E.A., and Nutman T.B. Tropical pulmonary eosinophilia. Annual Review of Medicine 43 (1992) 417-424
59. Ottesen E.A., and Weil G. Towards a strategic plan for research to support the Global Programme to Eliminate Lymphatic Filariasis-introduction. American Journal of Tropical Medicine and Hygiene 71 supplement (2004) 1-2
60. Pedersen E.M., and Mukoko D.A. Impact of insecticide-treated materials on filaria transmission by the various species of vector mosquito in Africa. Annals of Tropical Medicine and Parasitology 96 supplement 2 (2002) S91-S95
61. Rahmah N., Shenoy R.K., Nutman T.B., Weiss N., Gilmour K., Maizels R.M., Yazdanbakhsh M., and Sartono E. Multicentre laboratory evaluation of Brugia rapid dipstick test for detection of brugian filariasis. Tropical Medicine and International Health 8 (2003) 895-900
62. Ramaiah K.D., Das P.K., Michael E., and Guyatt H. The economic burden of lymphatic filariasis in India. Parasitology Today 16 (2000) 251-253
63. Ramzy, R., El Setouhy, M., Helmy, H., Ahmed, E., Abdel Aziz, K., Farid, H. and Weil, G. (2006). Comprehensive monitoring of the impact of mass drug administration with diethylcarbamazine and albendazole on Bancroftian filariasis in Egypt. Lancet.
64. Ramzy R., Goldman A., and Kamal H. Defining the cost of the Egyptian lymphatic filariasis elimination program. Filaria Journal 4 (2005) 7
65. Rawlins S.C., Siung-Chang A., Baboolal S., and Chadee D.D. Evidence for the interruption of transmission of lymphatic filariasis among school children in Trinidad and Tobago. Transactions of the Royal Society of Tropical Medicine and Hygiene 98 (2004) 473-477
66. Reuben R., Rajendran R., Sunish I.P., Mani T.R., Tewari S.C., Hiriyan J., and Gajanana A. Annual single-dose diethylcarbamazine plus ivermectin for control of Bancroftian filariasis: comparative efficacy with and without vector control. Annual Tropical Medicine Parasitology 95 (2001) 361-378
67. Sasa, M. (1976). Human Filariasis. A Global Survey of Epidemiology and Control, pp. 819. Tokyo: University Park Press.
68. Schlemper B.R.J., Steindel M., Grisard E.C., Carvalho-Pinto C.J., Bernardini O.J., de Castilho C.V., Rosa G., Kilian S., Guarneri A.A., Rocha A., Medeiros Z., and Ferreira Neto J.A. Elimination of Bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina State, Brazil. Tropical Medicine and International Health 5 (2000) 848-854
69. Seim A.R., Dreyer G., and Addiss D.G. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Revista de Sociedade Brasileira de Medicina Tropical 32 (1999) 325-328
70. Shin J.L., Gardiner G.W., Deitel W., and Kandel G. Does whipworm increase the pathogenicity of Campylobacter jejuni? A clinical correlate of an experimental observation. Canadian Journal of Gastroenterology 18 (2004) 175-177
71. Sprent J.F. Parasitology in Brisbane. International Journal of Parasitology 16 (1986) 281-285
72. Stephenson L.S., Latham M.C., and Ottesen E.A. Malnutrition and parasitic helminth infections. Parasitology 121 supplement (2000) S23-S38
73. Stolk W.A., Swaminathan S., van Oortmarssen G.J., Das P.K., and Habbema J.D. Prospects for elimination of Bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. Journal of Infectious Diseases 188 (2003) 1371-1381
74. Taylor M.J., Makunde W.H., McGarry H.F., Turner J.D., Mand S., and Hoerauf A. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet 365 (2005) 2116-2121
75. The Editorial Board of Control of Lymphatic Filariasis in China. (2003). Control of Lymphatic Filariasis in China, 230pp. World Health Organization Regional Office for the Western Pacific, Manila.
76. Vaqas B., and Ryan T.J. Lymphoedema: pathophysiology and management in resource-poor settings-relevance for lymphatic filariasis control programmes. Filaria Journal 2 (2003) 4
77. Wartman W.B. Filariasis in American armed forces in World War II. Medicine 26 (1947) 27-38
78. Webber R.H. Vector control of filariasis in the Solomon Islands. Southeast Asian Journal of Tropical Medical Public Health 6 (1975) 430-434
79. Weil G.J., Lammie P.J., and Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of Bancroftian filariasis. Parasitology Today 13 (1997) 401-404
80. Williams S.A., Laney S.J., Bierwert L.A., Saunders L.J., Boakye D.A., Fischer P., Goodman D., Helmy H., Hoti S.L., Vasuki V., Lammie P.J., Plichart C., Ramzy R.M.R., and Ottesen E.A. Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of Bancroftian filariasis. Annual Tropical Medicine Parasitology 96 (2002) S41-S46
81. Witt C., and Ottesen E.A. Lymphatic filariasis: an infection of childhood. Tropical Medicine and International Health 6 (2001) 582-606
82. World Health Organization (1995). World Health Report, 118pp. Geneva, Switzerland: World Health Organization.
83. World Health Organization (1999). Building Partnerships for Lymphatic Filariasis Strategic Plan (September 1999), 64pp. WHO/FIL 99.1998. Geneva, Switzerland: World Health Organization.
84. World Health Organization (2000). Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis, Geneva, Switzerland: World Health Organization 65pp. WHO/CDC/CPE/CEE/200.15.
85. World Health Organization (2004a). Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the GPELF. Weekly Epidemiological Record 79, 358-365.
86. World Health Organization (2004b). Lymphatic filariasis: progress of disability prevention activities. Weekly Epidemiological Record 79, 417-424.
87. World Health Organization (2005a). Global Programme to Eliminate Lymphatic Filariasis: progress report for 2004. Weekly Epidemiological Record 80, 202-212.
88. World Health Organization (2005b). Monitoring and Epidemiological Assessment of the Programme to Eliminate Lymphatic Filariasis at Implementation Unit Level. Geneva, Switzerland: World Health Organization, WHO/CDS/CPE/CEE 2005.50.
89. World Health Organization (2005c). Strategic and Technical Meeting on Intensified Control of Tropical Diseases. http://www.who.int/neglected diseases/rationale, (accessed August 2005).
90. Zhong M., McCarthy J., Bierwert L., Lizotte-Waniewski M., Chanteau S., Nutman T.B., Ottesen E.A., and Williams S.A. A polymerase chain reaction assay for detection of the parasite Wuchereria bancrofti in human blood samples. American Journal of Tropical Medicine and Hygiene 54 (1996) 357-363